TP53 and malignant colon neoplasm: To investigate downstream TP53 target genes involved in 5-fluorouracil (5-FU) resistance, Adamsen et al compared gene expression changes after 5-FU treatment in colon cancer cells with wild type or mutant TP53 [29].